Retrospective analysis of tumor programmed death-ligand 1 expression in transbronchial biopsy samples

被引：0

作者：

Takahashi, Hirofumi ^{[1
]}

Shinagawa, Naofumi ^{[1
]}

Hatanaka, Yutaka ^{[2
]}

Kunisaki, Mamoru ^{[1
]}

Furuta, Megumi ^{[1
]}

Takashima, Yuuta ^{[1
]}

Shouji, Tetuaki ^{[1
]}

Kitai, Hidenori ^{[1
]}

Kikuchi, Hajime ^{[1
]}

Mizugaki, Hidenori ^{[1
]}

Asahina, Hajime ^{[1
]}

Kikuchi, Eiki ^{[1
]}

Kikuchi, Jyunko ^{[1
]}

Sakakibara, Jyun ^{[1
]}

Matsuno, Yoshihiro ^{[3
]}

Nishimura, Masaharu ^{[1
]}

机构：

[1] Hokkaido Univ, Sch Med, Dept Med 1, Sapporo, Hokkaido, Japan

[2] Hokkaido Univ Hosp, Res Div Genome Compan Diagnost, Sapporo, Hokkaido, Japan

[3] Hokkaido Univ Hosp, Dept Surg Pathol, Sapporo, Hokkaido, Japan

来源：

EUROPEAN RESPIRATORY JOURNAL | 2018年 / 52卷

关键词：

D O I：

10.1183/13993003.congress-2018.PA2806

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

PA2806

引用

页数：2

共 50 条

[21] The expression of programmed death-ligand 1 and programmed death-ligand 2 in endometrial carcinosarcoma: Correlation with mismatch repair protein expression status, tumor-infiltrating lymphocyte infiltration, and clinical outcomes
Atilgan, Alev Ok
Tepeoglu, Merih
Ozen, Ozlem
Reyhan, A. Nihan Haberal
Ayhan, Ali
ANNALS OF DIAGNOSTIC PATHOLOGY, 2023, 65
[22] Epigenetic regulators of programmed death-ligand 1 expression in human cancers
Kumar, Sachin
Sharawat, Surender Kumar
TRANSLATIONAL RESEARCH, 2018, 202 : 129 - 145
[23] Clinical significance of programmed death-1 and programmed death-ligand 1 expression in the tumor microenvironment of clear cell renal cell carcinoma
Mikami, Shuji
Mizuno, Ryuichi
Kondo, Tsunenori
Shinohara, Nobuo
Nonomura, Norio
Ozono, Seiichiro
Eto, Masatoshi
Tatsugami, Katsunori
Takayama, Tatsuya
Matsuyama, Hideyasu
Kishida, Takeshi
Oya, Mototsugu
CANCER SCIENCE, 2019, 110 (06) : 1820 - 1828
[24] Programmed death-ligand 1 expression in the immune compartment of colon carcinoma
Yilmaz, Osman
Pankaj, Amaya
Neyez, Azfar
Rickelt, Steffen
Taylor, Martin
Lang, Evan R.
Leijsen, Lieve
Dinaux, Anne
Shroff, Stuti G.
Crotty, Rory
Zhang, M. Lisa
Cerda, Sandra
Zhao, Qing
Ferrone, Cristina
Ting, David T.
Patil, Deepa T.
Yilmaz, Omer
Berger, David
Deshpande, Vikram
MODERN PATHOLOGY, 2022, 35 (11) : 1740 - 1748
[25] The expression of programmed death-ligand 1 in patients with invasive breast cancer
Meng, Yi
Wu, Hongyan
Yao, Yongzhong
Li, Rong
GLAND SURGERY, 2020, 9 (06) : 2106 - 2115
[26] Programmed death-ligand 1 expression in patients with primary or secondary myelofibrosis
Ibrahim, Moayed
Murphree, Catherine
Patel, Kirtesh
Mastrodomenico, Matthew
Saba, Nakhle S.
Safah, Hana
Schmid, Janet
Socola, Francisco
CANCER REPORTS, 2024, 7 (09)
[27] Programmed Death-ligand 1 Expression in Upper Tract Urothelial Carcinoma
Skala, Stephanie L.
Liu, Tzu-Ying
Udager, Aaron M.
Weizer, Alon Z.
Montgomery, Jeffrey S.
Palapattu, Ganesh S.
Siddiqui, Javed
Cao, Xuhong
Fields, Kristina
Abugharib, Ahmed E.
Soliman, Moaaz
Hafez, Khaled S.
Miller, David
Lee, Cheryl T.
Alva, Ajjai
Chinnaiyan, Arul M.
Morgan, Todd M.
Spratt, Daniel E.
Jiang, Hui
Mehra, Rohit
EUROPEAN UROLOGY FOCUS, 2017, 3 (4-5): : 502 - 509
[28] Programmed Death-Ligand 1 Expression in Sarcomas, a Clinical a Pathologic Study
Matthew, Stemm
Mackinnon, Alexander C.
MODERN PATHOLOGY, 2016, 29 : 22A - 23A
[29] Expression of Programmed Death-Ligand 1 and Programmed Death-1 in Patients with Extramammary Paget's Disease
Goto, Hiroyuki
Sugita, Kazunari
Yamamoto, Osamu
INDIAN JOURNAL OF DERMATOLOGY, 2021, 66 (02) : 169 - 173
[30] Heterogeneity of programmed cell death-ligand 1 expression in lung cancer
Mansfield, Aaron
Murphy, Stephen
Peikert, Tobias
Vasmatzis, George
Wigle, Dennis
Aubry, Marie Christine
JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (02) : S31 - S32

← 1 2 3 4 5 →